Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Dec 1;16(12):e74925.
doi: 10.7759/cureus.74925. eCollection 2024 Dec.

Trends in the Epidemiology of Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Surgery

Affiliations

Trends in the Epidemiology of Deep Vein Thrombosis and Pulmonary Embolism in Patients Undergoing Surgery

Shelby Cowan et al. Cureus. .

Abstract

Objective This study aims to utilize the TriNetX database, a comprehensive global network, to improve our understanding of the frequency, demographic factors, and related comorbidities of surgical patients who develop venous thromboembolism (VTEs) events. Methods The global collaborative network in TriNetX was queried for all cases from January 1, 2017, through December 31, 2023. International Classification for Disease (ICD) diagnosis codes were used to define patient cohorts with deep vein thrombosis (DVT) of the upper or lower extremity or pulmonary embolism (PE). Patient information was extracted including age, sex, ethnicity, race status, and comorbidities. We assumed that PE occurred following a DVT which is only reported once as a PE, and not a DVT. Results The study included 414,045 patients with lower extremity DVT, 82,800 with upper extremity DVT, and 508,044 with reported PE following a DVT. DVT and PE account for approximately 51% and 49% of VTE cases, respectively, with differences noted based on age, sex, ethnicity, race, and comorbidities. The data showed that advanced age, higher BMI, and Black race are associated with a higher risk of thromboembolism. Common comorbidities, such as cardiac dysrhythmias, a history of thromboembolism, cancer, and renal failure are prevalent across all three diagnostic groups. Conclusion The study results suggest that the incidence and prevalence of VTE are changing due to the aging population and changes in demographic patterns. Healthcare services should consider planning for the changes in morbidity, mortality, and related healthcare costs. Surgical patients with multiple related comorbidities should be managed to prevent VTEs more aggressively with close monitoring for any evolving VTE.

Keywords: deep vein thrombosis (dvt); factor v leiden deficiency; lower extremity dvt; medical comorbidities; upper extremity dvt; venous thromboembolism (vte); vte prophylaxis.

PubMed Disclaimer

Conflict of interest statement

Human subjects: Consent for treatment and open access publication was obtained or waived by all participants in this study. Animal subjects: All authors have confirmed that this study did not involve animal subjects or tissue. Conflicts of interest: In compliance with the ICMJE uniform disclosure form, all authors declare the following: Payment/services info: All authors have declared that no financial support was received from any organization for the submitted work. Financial relationships: All authors have declared that they have no financial relationships at present or within the previous three years with any organizations that might have an interest in the submitted work. Other relationships: All authors have declared that there are no other relationships or activities that could appear to have influenced the submitted work.

Figures

Figure 1
Figure 1. Bar Graph Showing Incidence of Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) From 2017 to 2023
Figure 2
Figure 2. Bar Graph Showing Proportion of Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) Cases by Age Group
Figure 3
Figure 3. Bar Graph Showing the Percentage of Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) Cases by Sex
Figure 4
Figure 4. Bar Graph Showing the Percentage of Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) Cases by Race
Figure 5
Figure 5. Bar Graph Depicting the Proportion of Patients With Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) Who Have Comorbidities Related to Coagulation
Figure 6
Figure 6. Bar Graph Showing the Percentage of Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) Patients With Certain Cardiovascular Comorbidities
Figure 7
Figure 7. Bar Graph Showing the Proportion of Lower Extremity Deep Vein Thrombosis (LE DVT), Upper Extremity Deep Vein Thrombosis (UE DVT), and Pulmonary Embolism (PE) Patients With Additional Comorbidities
DM with Cxs: diabetes mellitus with complications; IBD: inflammatory bowel disease

Similar articles

Cited by

References

    1. Badireddy M, Mudipalli VR. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023. Deep venous thrombosis prophylaxis. - PubMed
    1. Venous thromboembolism prophylaxis in major orthopedic surgeries and factor XIa inhibitors. Jones A, Al-Horani RA. https://doi.org/10.3390/medsci11030049. Med Sci (Basel) 2023;11:49. - PMC - PubMed
    1. An update on venous thromboembolism rates and prophylaxis in hip and knee arthroplasty in 2020. Santana DC, Emara AK, Orr MN, et al. https://doi.org/10.3390/medicina56090416. Medicina (Kaunas) 2020;56:416. - PMC - PubMed
    1. Venous thromboembolism in orthopedic surgery: global guidelines. Uzel K, Azboy İ, Parvizi J. https://doi.org/10.5152/j.aott.2023.23074. Acta Orthop Traumatol Turc. 2023;57:192–203. - PMC - PubMed
    1. Nonunion fractures: trends in epidemiology and treatment of femur fractures, 2017-2022. Ghayyad K, Escobar P, Beaudoin TF, Wandersleben L, Hawks M, Ahmed A, Kachooei AR. Cureus. 2024;16:0. - PMC - PubMed

LinkOut - more resources